Newsletter Signup | Community
Cancer Connect - Treatment of Stage II Melanoma
Combining T-VEC Herpes Virus With Keytruda Immunotherapy Shows Promise for Treating Advanced Melanoma
Yervoy + Opdivo Improves Overall Survival in Advanced Melanoma; Average Survival May Exceed 4 Years
Cancer Connect - Treatment of In Situ & Stage 1 Melanoma
Keytruda® Continues to have Improved Survival Benefit Compared to Yervoy® in Advanced Melanoma.
Biomarkers drive new drug development in melanoma
A new very active treatment option for Melaoma-Braftovi